Acute Care Management in Breast Cancer

- Abuhelwa, Z., Alloghbi, A., Alqahtani, A., & Nagasaka, M. (2022). Trastuzumab deruxtecan-induced interstitial lung disease/pneumonitis in ERBB2-positive advanced solid malignancies. Drugs, 82(9), 979–987. https://doi.org/10.1007/s40265-022-01736-w

- American Joint Committee on Cancer. (2017). Breast cancer staging overview: AJCC 8th edition. https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC%208th%20Ed%20Cancer%20Staging%20Manual.pdf

- Antiemesis. (2024). NCCN Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf

- Bashour, S., Mankidy, B., & Lazarus, D. (2022). Update on the diagnosis and management of malignant pleural effusions. Respiratory Medicine, 196, 106802. https://doi.org/10.1016/j.rmed.2022.106802

- Belluomini, L., & Pilotto, S. (2024). Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management. Critical Reviews in Oncology/Hematology, 201, 104444. https://doi.org/10.1016/j.critrevonc.2024.104444

- Benvenuti, C., Gaudio, M., Jacobs, F., Saltalamacchia, G., De Sanctis, R., Torrisi, R., & Zambelli, A. (2023). Clinical review on the management of breast cancer visceral crisis. Biomedicines, 11(4), 1083. https://doi.org/10.3390/biomedicines11041083

- Berger, J. M., Preusser, M., Berghoff, A. S., & Bergen, E. S. (2023). Malignant ascites: Current therapy options and treatment prospects. Cancer Treatment Reviews, 121, 102646. https://doi.org/10.1016/j.ctrv.2023.102646

- Gautam, S., Sharma, K. K., & Amanat, M. (2023). Management of chemotherapy-induced nausea and vomiting in breast cancer patients. Journal of Radiology Nursing, 42(3), 315–320. https://doi.org/10.1016/j.jradnu.2023.04.002

- Gutierrez, C., McEvoy, C., Munshi, L., et al. (2020). Critical care management of toxicities associated with targeted agents and immunotherapies for cancer. Critical Care Medicine, 48(1), 10–21. https://doi.org/10.1097/CCM.0000000000004087

- Hesketh, P. J., Kris, M. G., Basch, E., et al. (2020). Antiemetics: ASCO guideline update. Journal of Clinical Oncology, 38(24), 2782–2797. https://doi.org/10.1200/JCO.20.01296

- International Agency for Research on Cancer, World Health Organization. (2024). GLOBOCAN 2024: Cancer fact sheets.

- Kichloo, A., Albosta, M., Dahiya, D., et al. (2021). Systemic adverse effects and toxicities associated with immunotherapy: A review. World Journal of Clinical Oncology, 12(3), 150–163. https://doi.org/10.5306/wjco.v12.i3.150

- Lin, M. X., Zang, D., Liu, C. G., Han, X., & Chen, J. (2024). Immune checkpoint inhibitor-related pneumonitis: Advances in prediction and management. Frontiers in Immunology, 15, Article 00000. https://doi.org/10.3389/fimmu.2024.00000

- MD Anderson Cancer Center. (2024). Palliative management of bowel obstruction. https://www.mdanderson.org/content/dam/mdanderson/documents/for-physicians/algorithms/clinical-management/clin-management-bowel-obstruction-web-algorithm.pdf

- Nogueira, R. M., Bernabé, D. G., & Carvalho, M. B. (2022). Interventions for radiation-induced fibrosis in breast cancer: Systematic review and meta-analysis. Advances in Radiation Oncology, 7(3), 100912. https://doi.org/10.1016/j.adro.2022.100912

- Orrantia-Borunda, E., Anchondo-Nuñez, P., Acuña-Aguilar, L. E., et al. (2022). Subtypes of breast cancer. In H. N. Mayrovitz (Ed.), Breast cancer (Chap. 3). Exon Publications. https://doi.org/10.36255/exon-publications-breast-cancer-subtypes

- Rai, A., Deshpande, S. G., Vaidya, A., & Shinde, R. K. (2024). Advancements in immunotherapy for breast cancer. Cureus, 16(8), e68351. https://doi.org/10.7759/cureus.68351

- Rashid, N. S., Grible, J. M., Clevenger, C. V., & Harrell, J. C. (2021). Breast cancer liver metastasis: Current and future treatment approaches. Clinical & Experimental Metastasis, 38(3), 263–277. https://doi.org/10.1007/s10585-021-10080-4

- Seiler, S., Kosse, J., Loibl, S., & Jackisch, C. (2014). Management of oral mucositis in breast cancer. Breast Care, 9(4), 232–237. https://doi.org/10.1159/000366246

- Shalata, W., Abu-Salman, A., Steckbeck, R., Jacob, B. M., Massalha, I., & Yakobson, A. (2021). Cardiac toxicity associated with immune checkpoint inhibitors: A systematic review. Cancers, 13(20), 5218. https://doi.org/10.3390/cancers13205218

- Sookprasert, A., Chindaprasirt, J., Wirasorn, K., Limpawattana, P., & Thavornpitak, Y. (2012). Patterns of chemotherapy usage in hospitalized breast cancer patients. Journal of the Medical Association of Thailand, 95(Suppl. 7), S206–S210.

- Vuger, A. T., Tiscoski, K., Apolinario, T., & Cardoso, F. (2022). Anthracyclines in the treatment of early breast cancer: Friend or foe? Breast, 65, 67–76. https://doi.org/10.1016/j.breast.2022.06.007

- World Health Organization. (n.d.). Breast cancer. https://www.who.int/news-room/fact-sheets/detail/breast-cancer